H-FABP与BNP在快速心房纤颤诊断与评估中的应用

摘要/Abstract

摘要： 目的旨在研究心脏型脂肪酸结合蛋白（H-FABP）与前体B型钠尿肽（pro-BNP）在快速心房纤颤（简称房颤）中的诊断和评估价值。方法应用双抗夹心酶联免疫吸附试验（ELISA）对2021年1月至2022年12月间,潍坊市坊子区人民医院急诊收治的79例快速房颤患者的血浆中H-FABP和pro-BNP进行检测。进一步结合患者的临床表现、心功能检测进行综合分析。结果在阵发性、持续性和永久性房颤患者中,血浆H-FABP的平均含量分别为（7.0±1.7）ng/mL、（8.3±2.2）ng/mL和（9.5±3.0）ng/mL,而pro-BNP的平均含量则分别为（819±125）pg/mL、（1630±215）pg/mL和（2189±165）pg/mL。阵发性房颤患者经过胺碘酮转复心律后,H-FABP和pro-BNP水平均显著下降至（6.2±1.1）ng/mL和（561±117）pg/mL。根据NYHA心功能分级,III级和IV级患者的H-FABP和pro-BNP含量显著高于心功能较好的患者。结论 H-FABP和pro-BNP的血浆水平与快速房颤患者的心功能状态显著关联,因此有潜力作为房颤诊断和心功能评估的生物标志物。

关键词: 心房纤颤, H-FABP, pro-BNP, 心功能状态

Abstract: Objective To investigate the value of heart-type fatty acid-binding protein (H-FABP) andpro-B-type natriuretic peptide (proBNP) in the diagnosis and evaluation of rapid atrial fibrillation. Methods A total of 79 patients with rapid atrial fibrillation who were admitted to Department of Emergency, The People's Hospital of Fangzi District, from January 2021 to December 2022 were enrolled, and double-antibody sandwich enzyme-linked immunosorbent assay was used to measure the plasma levels of H-FABP and proBNP. A comprehensive analysis was performed based on clinical manifestation and cardiac function testing. Results The mean level of plasma H-FABP was (7.0±1.7)ng/mL in patients with paroxysmal atrial fibrillation,(8.3±2.2)ng/mL in patients with persistent atrial fibrillation, and 9.5±3.0 ng/mL in patients with permanent atrial fibrillation, while the mean level of proBNP in these three groups of patients was (819±125)pg/mL,(1630±215)pg/mL, and (2189±165)pg/mL, respectively. For the patients with paroxysmal atrial fibrillation, the levels of H-FABPand proBNP were reduced significantly to (6.2±1.1)ng/mL and (561±117)pg/mL, respectively, after cardioversion with amiodarone. Based on NYHA classification for cardiac function, the patients with grade III/IV cardiac function had significantly higher levels of H-FABPand proBNP than those with good cardiac function. Conclusion The plasma levels of H-FABPand proBNP are significantly associated with the cardiac function of patients with rapid atrial fibrillation, and therefore, they can be used as potential biomarkers for the diagnosis of atrial fibrillation and the evaluation of cardiac function.

Key words: Coronary artery, Elderly patients, Interventional therapy, Percutaneous radial artery puncture, Femoral artery puncture

高翔, 李伟真, 于立涛, 刘艳, 郑晓静. H-FABP与BNP在快速心房纤颤诊断与评估中的应用[J]. 心血管病防治知识, 2024, 14(1): 42-45.

GAO Xiang, LI Wei-zhen, YU Li-tao, LIU Yan, ZHENG Xiao-jing. Application of heart-type fatty acid-binding protein and pro-B-type natriuretic peptide in the diagnosis and evaluation of rapid atrial fibrillation[J]. Prevention and Treatment of Cardiovascular Disease, 2024, 14(1): 42-45.

参考文献

[1] 苗成林.血清cMyBP-C、H-FABP、CK-MB及BNP联合检测在早期急性心肌梗死患者诊断中的应用研究[J] .内蒙古医学杂志,2023,55(2):145-148.
[2] 孙欣娜,于泊,杨青, 等.川崎病CK-MB、NT-proBNP、H-FABP和冠状动脉Z值的变化及其与冠脉病变的相关性研究[J] .临床和实验医学杂志,2022,21(13):1384-1387.
[3] 聂凤英. 慢性心力衰竭患者血清H-FABP、Gal-3、GDF-15、pro-BNP水平变化及意义[J] .中国卫生工程学,2022,21(2):303-304, 309.
[4] 苏运璞,孔双燕,刘赛顶.24h DCG联合血清BNP、IMA、H-FABP对老年冠心病并发无症状心肌缺血的诊断价值[J] .中国卫生工程学,2021,20(3):478-480, 483.
[5] 宋虹,汤楚中,何清.AMI患者PCI术前后血清H-FABP、BNP、hsCRP、hscTnT水平变化及其与预后的关系[J] .心血管康复医学杂志,2021,30(2):147-151.
[6] 尹浡,杜鹏,夏开.喜格迈治疗对急性非ST段抬高心肌梗死PCI术后患者心功能及血清CK-MB、MYO、cTnI、BNP、H-FABP水平的影响[J] .内科,2020,15(3):268-271.
[7] 薛炎,王立新,周帆, 等.血清BNP、CK-MB、H-FABP水平早期动态检测对先心病合并肺炎患儿病情评估的临床价值[J] .临床和实验医学杂志,2020,19(3):282-286.
[8] 黄远东,宋宁,唐丹丹.NLR、H-FABP、BNP在急性肺栓塞中的表达水平及意义[J] .中国医学前沿杂志(电子版),2019,11(9):69-72.
[9] 丁丹. H-FABP联合BNP评估急性心肌梗死早期心功能的价值[D] .吉首大学,2019.
[10] 李怡霖,魏庆民,吕静, 等.血清H-FABP水平在不同程度左室射血分数保留的心力衰竭患者中的相关性研究[J] .中西医结合心血管病电子杂志,2018,6(22):20-21.
[11] 田梅香. 不同治疗策略对心房颤动患者生活质量、家庭功能、焦虑和抑郁的影响及关系研究[D] .兰州大学,2023.
[12] 陈龙,方国建,唐东方等.巴卡亭Ⅲ对心房纤维化的作用及其机制研究[J] .宁波大学学报(理工版),2022,35(5):107-114.
[13] 游月婷. 心力衰竭合并心房颤动患者的相关危险因素研究[D] .西南交通大学,2022.
[14] 马宗宾,赵永辉,刘倩玲.心房颤动合并心力衰竭的治疗进展[J] .中国动脉硬化杂志,2022,30(6):535-540.
[15] 黄玲,陈灿.心房颤动的上游治疗研究[J] .医学信息,2021,34(19):51-54.
[16] 杨昊,陈多闻,伍业载, 等.CRP、NT-proBNP和Fib联合检测对慢性心房颤动并发心力衰竭的诊断价值[J] .检验医学与临床,2021,18(15):2248-2250.
[17] 张荣峰,夏云龙.心房颤动介导的心肌病[J] .大连医科大学学报,2021,43(1):75-78.
[18] 高振华,靳飞鹏,孟银苔,等.血清sST2、H-FABP、Clusterin对冠心病患者PCI术后主要不良心血管事件的预测价值分析[J] .医药论坛杂志,2023,44(17):9-13.